The North America Point-of-care Ultrasound Market would witness market growth of 13.1% CAGR during the forecast period (2023-2030).In the year 2019, the North America market's volume surged to 39,473.2 units, showcasing a growth of 14.0% (2019-2022).
Point-of-care (POC) ultrasound is crucial for many possible clinical uses, including real-time imaging-guided treatments during surgery and access to diagnostic imaging. The point-of-care application devices help patients in specialty clinics, ambulatory surgical facilities, and primary health centres by providing early bedside evaluation of primary therapy and emergency screening.
There is a greater transition toward inpatient care to outpatient care in nowadays healthcare environment. As a result, they have become an increase in demand for ultrasound equipment to be used at the point of care. Additionally, the need for point-of-care ultrasound devices has increased due to the demand for emergency medicine and intensive care, including cardiology and obstetrics. Furthermore, many technologically advanced products have been introduced owing to the strong tendency toward cutting-edge R&D among prominent companies.
Significant initiatives have been made to increase the effectiveness and accuracy of diagnostic testing, especially through the use of point-of-care testing, in order to shorten the period between the emergence of symptoms and the beginning of crucial therapy. Triage and diagnostics durations must be sped up to lower morbidity and mortality in critically ill patients. Point-of-care testing is beneficial in achieving these goals since it increases operational efficiency and eventually leads to better patient outcomes. Point-of-care ultrasound (POCUS) is one of the point-of-care testing alternatives available to emergency physicians.
The first Canadian study of chronic kidney disease (CKD) in primary care, which analysed data from 5 provinces throughout the country, recently estimated the prevalence of CKD to be 71 per 1000 people. The CDC also report that 34% of adults 65 and older have CKD, which is most prevalent in this age group. 35.5 million Americans, or more than 1 in 7, have CKD, accounting up 14% of US adults. Point-of-care ultrasound is expected to become more popular as CKD and cancer become increasingly prevalent.
The US market dominated the North America Point-of-care Ultrasound Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $726.9 Million by 2030. The Canada market is experiencing a CAGR of 15.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 14.6% during (2023 - 2030).
Based on End User, the market is segmented into Hospitals, Clinics, and Others. Based on Product, the market is segmented into Cart-based, and Compact & Hand-held. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Point-of-care Ultrasound Market is Projected to reach USD 3.2 Billion by 2030, at a CAGR of 13.8%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Koninklijke Philips N.V., FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Alpinion Medical Systems Co., Ltd. (ILJIN Group), Hitachi, Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Terason, Healcerion Co., Ltd., Edan Instruments, Inc. and Chilson Medical Technologies Co., Ltd.
By End User (Volume, Units, USD Million, 2019-2030)
By Product (Volume, Units, USD Million, 2019-2030)
By Country (Volume, Units, USD Million, 2019-2030)
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 